ALEXANDRIA, Egypt--(BUSINESS WIRE)--Pharco Pharmaceuticals, Inc. announced today that Gamal Esmat, M.D., Professor of Haepatology and Endemic Medicine at Cairo University and WHO viral hepatitis expert, will present advanced results of the abstract entitled: High Virologic Response Rate in Egyptian HCV-Genotype 4 Patients Treated with Ravidasvir (PPI-668) and Sofosbuvir: Results of a Large Multicenter Phase 3 Registrational Trial.
Help employers find you! Check out all the jobs and post your resume.
